Literature DB >> 8566612

Controlled clinical trials: the controls are the key.

D J Ahnen.   

Abstract

Mesh：

Year:  1996        PMID： 8566612     DOI： 10.1053/gast.1996.v110.agast960628

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  3 in total

1.  PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis.

Authors:  E V Loftus; G C Harewood; C G Loftus; W J Tremaine; W S Harmsen; A R Zinsmeister; D A Jewell; W J Sandborn
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

2.  Colonic cancer in a patient with primary sclerosing cholangitis and long-standing ulcerative colitis.

Authors:  M Seo; M Okada; S Osamura; S Hara; T Umeno; K Maeshiro; Y Yamada; K Yuh
Journal:  J Gastroenterol       Date:  1997-02       Impact factor: 7.527

3.  Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study.

Authors:  D Kornfeld; A Ekbom; T Ihre
Journal:  Gut       Date:  1997-10       Impact factor: 23.059
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.